civil-litigation injunction intellectual-property patent-litigation tort education federal-courts court-watch

The Board of Regents of the University of Texas System v. Alnylam Pharmaceuticals Inc. et al

25-cv-13865 D. Mass.
Active Active litigation Sign in to follow this case
Share mail
Advertisement
description

Case Summary

The Board of Regents of the University of Texas System v. Alnylam Pharmaceuticals Inc. et al is a civil case with an unknown court. The case was filed under docket number 25-cv-13865. The plaintiff, The Board of Regents of the University of Texas System, is suing Alnylam Pharmaceuticals Inc. et al for unspecified reasons. The case is ongoing.

No timeline activity recorded yet. This page will grow as rulings and filings land.

Key Issues

  • plaintiff
  • defendants
  • court
  • docket number
smart_toy Juryvine case summary generated from primary court records. How we verify our work.
fact_check

Docket Snapshot

account_balance

Court

D. Mass.

District of Massachusetts · 1st Circuit · MA

tag

Docket

Not captured

Civil

timeline

Stage

Active litigation

Active

event

Filed

Date unavailable

Not in the available feed

new_releases

Latest Filing

1:25-cv-13865 The Board of Regents of the University of Texas System v. Alnylam Pharmaceuticals Inc. et al

Other · Apr 23, 2026

newspaper

Coverage

1 article

1 source tracked

groups

Participants

1 Defendant, 1 Plaintiff

3 linked entities

gavel

Judge

Not assigned in feed

What the record shows

This case is tied to District of Massachusetts, a federal district court in MA.

The newest docket activity we have is a other dated April 23, 2026.

The visible party/entity graph currently includes Alnylam Pharmaceuticals Inc, 1:25-cv-13865 The Board of Regents of the University of Texas System and others.

Press monitoring has found 1 related article from 1 distinct source.

chronic

The Story So Far

Updated 1 day, 18 hours ago

The Board of Regents of the University of Texas System v. Alnylam Pharmaceuticals Inc. et al is an active civil matter in District of Massachusetts under docket 25-cv-13865.

The dispute currently identifies 1:25-cv-13865 The Board of Regents of the University of Texas System on one side and Alnylam Pharmaceuticals Inc on the other. The case is currently organized around defendants, docket number.

et al is a civil case with an unknown court. The case was filed under docket number 25-cv-13865. The plaintiff, The Board of Regents of the University of Texas System, is suing Alnylam Pharmaceuticals Inc.

et al for unspecified reasons. The case is ongoing.

On April 23, 2026, the docket recorded a other: The University of Texas System sued Alnylam Pharmaceuticals and other defendants for allegedly infringing on a patent related to RNA interference technology. The lawsuit seeks damages and an injunction to stop the defendants from using the technology. This.

The next thing to watch is whether the latest other produces a substantive order, a scheduling change, a settlement signal, or a filing that clarifies the parties' positions.

smart_toy Juryvine case narrative generated from the full docket timeline. How we verify our work.

About This Court

District of Massachusetts (D. Mass.) is a federal district court in the 1st Circuit, MA.

Advertisement

Case Timeline

1 event
info
Other April 23, 2026

1:25-cv-13865 The Board of Regents of the University of Texas System v. Alnylam Pharmaceuticals Inc. et al

The University of Texas System sued Alnylam Pharmaceuticals and other defendants for allegedly infringing on a patent related to RNA interference technology. The lawsuit seeks damages and an injunction to stop the defendants from using the technology. This case is significant because it involves a high-stakes patent dispute in the biotechnology industry.

Advertisement
newspaper

Press Coverage

1 article
settings_backup_restore Data provenance expand_more

Sources tracked

1 outlet · 1 article

Timeline events

1 record on file

Last updated

1 day, 18 hours ago

Juryvine aggregates docket entries from PACER/CourtListener, press coverage, and GDELT signals. Ingestion timestamps do not appear in the What Changed feed — that reflects real court activity only.